June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Novel hyaluronic acid-based corneal stromal replacement
Author Affiliations & Notes
  • Alfonso Iovieno
    The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada
  • Roza Ghaemi
    The University of British Columbia, Vancouver, British Columbia, Canada
  • Vikramaditya Yadav
    The University of British Columbia, Vancouver, British Columbia, Canada
  • Sonia Yeung
    The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada
  • Footnotes
    Commercial Relationships   Alfonso Iovieno None; Roza Ghaemi None; Vikramaditya Yadav None; Sonia Yeung None
  • Footnotes
    Support  EBAA Pilot grant (7500 USD), UBC New Faculty grant (10000 CAD)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2641. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alfonso Iovieno, Roza Ghaemi, Vikramaditya Yadav, Sonia Yeung; Novel hyaluronic acid-based corneal stromal replacement. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2641.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To develop a durable, biocompatible, transparent, artificial corneal stromal substitute that would mimic the human corneal stroma in key physical and physiological functions

Methods : a hyaluronic acid (HA)-based 500 μm hydrogel was fabricated and then crosslinked. Compounds ratios as well as crosslinking condition was systematically evaluated by assessing swelling ratio (hydrogel weight after submerging in PBS), mechanical strength (rheometer with cone-and-plate geometry), biodegradability (remaining weight after submerging in an enzyme cocktail), optical transparency (spectrophotometer at UV-Visible wavelengths) and glucose/albumin permeability (glucose and albumin concentration across the hydrogel) of the resulting hydrogels. The hydrogel was then coated with an antiangiogenic compound to prevent neovascularization

Results : all composites were completely clear (>88% transmittance) with refractive index of ~1.3, which is very close to that of the human cornea. Hydrogels were shown to have an equilibrium water content of ~90% with less than 5% degradation in enzymatic solution over 2 months. Tensile strength and maximum elongation of the hydrogels were found to be 1.47 MPa and 8.57% respectively, which are comparable to native cornea. The presence of the specific bonds in the hydrogel structure and the crosslinking of the antiangiogenic compound coating on the walls were confirmed by Fourier Transform Infrared Spectra

Conclusions : We have been able to produce a hyaluronic acid-based co-polymer with optical and mechanical properties similar to the human corneal stroma. Further studies would be needed to test biocompatibility in vitro and in animal models

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×